Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE

Detalles Bibliográficos
Autores principales: Gooderham, Melinda J., Chu, Chia-Yu, Rojo, Ricardo, Valdez, Hernan, Biswas, Pinaki, Cameron, Michael C., Feeney, Claire, Encinas, Gerardo A., Peeples-Lamirande, Kathleen, Cappelleri, Joseph C., Myers, Daniela E., DiBonaventura, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361901/
https://www.ncbi.nlm.nih.gov/pubmed/34409391
http://dx.doi.org/10.1016/j.jdin.2021.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361901/
https://www.ncbi.nlm.nih.gov/pubmed/34409391
http://dx.doi.org/10.1016/j.jdin.2021.05.004

Ejemplares similares